Velactis
cabergoline
Date of authorisation:
Revision: 1
Last updated:
MedicineVeterinaryWithdrawn
EMEA-001487-PIP01-13 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Ophthalmology
PIP number: P/0148/2014
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Solution for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-001487-PIP02-15 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Immunology-Rheumatology-Transplantation
PIP number: P/0253/2015
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Solution for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Ergot-derived dopamine agonists - referral
bromocriptine
cabergoline
dihydroergocryptine
lisuride
pergolide
Article 31 referrals
Status: European Commission final decision
Opinion/position date:
Last updated:
ReferralHuman